Efisalin, created in 1951 (Germany), from
2466 sister brands
and 17478 competing brands.
Efisalin is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York
The sector of Efisalin is Drug Manufacturers.
Efisalin is a brand of JOHNSON & JOHNSON (JNJ) News
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.